Typicality: | 0.478 |
Saliency: | 0.534 |
tuesday | 3 | temporal |
with no adverse effects | 2 | other |
in the journal | 2 | location |
researcher → say in → study | 58 |
researcher → say in → the study | 45 |
researcher → say in → this study | 4 |
negative | neutral | positive |
0.211 | 0.563 | 0.226 |
Raw frequency | 107 |
Normalized frequency | 0.534 |
Modifier score | 0.500 |
Perplexity | 274.900 |